Pfizer’s Center for Digital Innovation (CDI) in Thessaloniki is making a considerable contribution not only to the local economy but also to the country’s gross domestic product and tax revenues, a survey by the Foundation for Economic and Industrial Research (IOBE) has shown.
For the decade between 2020 and 2030 the research hub of the pharmaceutical multinational is estimated to contribute a total of 486 million euros to the Greek GDP, while its overall contribution to tax revenues is calculated at €169 million for the same period. The IOBE research also shows that every euro of added value generated by the operation of CDI contributes 2 euros to the Greek GDP.
The center is also valuable at the regional level, with €447 million generated over the above decade concerning Thessaloniki’s economy. CDI Finance Partner Dimitris Papakonstantinou stated that, “for CDI, Thessaloniki is not just the base of our headquarters. The center works and grows within the city and together with the city, gains from its human resources and talents, collaborates with the local innovation ecosystem and supports Thessaloniki, recognizing that the progress of the city is a profit for everyone.”